OINDPNEWS.COM: Keyword Density Checker

Total words: 2278 | 2-word phrases: 586 | 3-word phrases: 646 | 4-word phrases: 674

PAGE INFO

Title	Try to keep the title under 60 characters (9 characters) OINDPnews
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	… read more	7	1.08%
2	read more about	6	0.93%
3	spray as a	3	0.46%
4	nda for ox124	3	0.46%
5	nasal spray as	3	0.46%
6	with catalent for	3	0.46%
7	phase 2a trial	3	0.46%
8	that it has	2	0.31%
9	crl to orexo’s	2	0.31%
10	lonza’s kimberly shepard	2	0.31%
11	fda issues crl	2	0.31%
12	issues crl to	2	0.31%
13	jj submits snda	2	0.31%
14	submits snda for	2	0.31%
15	the fda has	2	0.31%
16	esketamine nasal spray	2	0.31%
17	narcan naloxone nasal	2	0.31%
18	highlighted an industry	2	0.31%
19	as a monotherapy	2	0.31%
20	a monotherapy for	2	0.31%
21	shepard answers questions	2	0.31%
22	naloxone nasal powder	2	0.31%
23	industry in transition	2	0.31%
24	resubmitted nda for	2	0.31%
25	an industry in	2	0.31%
26	kimberly shepard answers	2	0.31%
27	questions about spray	2	0.31%
28	answers questions about	2	0.31%
29	of phase 2a	2	0.31%
30	emergent biosolutions’ narcan	2	0.31%

#	Keyword	Frequency	Density
1	… read more about	5	0.74%
2	nasal spray as a	3	0.45%
3	2024 to cover the	2	0.30%
4	spray gets shelflife extension	2	0.30%
5	capsules and blisters clinical	2	0.30%
6	and blisters clinical technology	2	0.30%
7	expansion of phase 2a	2	0.30%
8	of phase 2a trial	2	0.30%
9	consultants contract research contract	2	0.30%
10	contract research contract manufacturing	2	0.30%
11	research contract manufacturing devices	2	0.30%
12	contract manufacturing devices education	2	0.30%
13	phase 2a trial neonc’s	2	0.30%
14	gets shelflife extension in	2	0.30%
15	shelflife extension in canada	2	0.30%
16	excipients filling equipment instruments	2	0.30%
17	equipment instruments particle manufacturing	2	0.30%
18	filling equipment instruments particle	2	0.30%
19	alcohol to include additional type	2	0.30%
20	include additional type of	2	0.30%
21	questions about spray drying	2	0.30%
22	answers questions about spray	2	0.30%
23	shepard answers questions about	2	0.30%
24	kimberly shepard answers questions	2	0.30%
25	lonza’s kimberly shepard answers	2	0.30%
26	resubmitted nda for ox124	2	0.30%
27	issues crl to orexo’s	2	0.30%
28	for the reversal of	2	0.30%
29	fda issues crl to	2	0.30%
30	highlighted an industry in	2	0.30%
31	an industry in transition	2	0.30%
32	esketamine nasal spray as	2	0.30%
33	jj submits snda for	2	0.30%
34	spray as a monotherapy	2	0.30%
35	catalent for services related	2	0.30%
36	to cover the latest	2	0.30%
37	as a monotherapy for	2	0.30%
38	for the treatment of	2	0.30%
39	cordis announces expansion of	2	0.30%
40	read more about fda	2	0.30%

#	URL	Whois	Check
1	http://eepurl.com/c8pnEX	Whois	eepurl.com
2	https://www.ipacrs.org/biologics-workshop	Whois	ipacrs.org
3	https://www.copleyscientific.com/events/webinar-optimising-inhaled-and-nasal-product-testing-lower-variability-higher-productivity/	Whois	copleyscientific.com
4	https://ddl-conference.com/new-researcher-network-summer-event-2024/	Whois	ddl-conference.com
5	https://newaurameeting.it/international-conference-and-galenus-workshop/	Whois	newaurameeting.it
6	https://www.intertek.com/pharmaceutical/events/inhaled-nasal-biologics-dna-forum/	Whois	intertek.com
7	https://hwll.co/solstice-air-oindp	Whois	hwll.co
8	https://bit.ly/4cKZyye	Whois	bit.ly